OPKO Health, Inc. Cash and Cash Equivalents, Period Increase (Decrease)
OPKO Health, Inc. (OPK) reported Cash and Cash Equivalents, Period Increase (Decrease) of $4.97 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-01.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2019-03-01
- OPKO Health, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-12-31 was $52.76M.
- OPKO Health, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-09-30 was -$36.66M.
- OPKO Health, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-06-30 was -$19.56M.
- OPKO Health, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-03-31 was $8.44M.
- OPKO Health, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2018 was $4.97M.
- OPKO Health, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2017 was -$77.23M.
- OPKO Health, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$24.86M.
- OPKO Health, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2014 was -$88.89M, a 156.10% decline from fiscal 2013.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2018-12-31 | $52.76M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $16.09M derived: sum of 2 quarters · filed 2019-03-01 | -$3.47M derived: sum of 3 quarters · filed 2019-03-01 | $4.97M 10-K · filed 2019-03-01 |
| 2018-09-30 | -$36.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$56.23M derived: sum of 2 quarters · filed 2018-11-09 | -$47.78M 10-Q · filed 2018-11-09 | -$56.64M derived: sum of 4 quarters · filed 2019-03-01 |
| 2018-06-30 | -$19.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$11.12M 10-Q · filed 2018-08-07 | -$19.98M derived: sum of 3 quarters · filed 2019-03-01 | -$50.15M derived: sum of 4 quarters · filed 2019-03-01 |
| 2018-03-31 | $8.44M 10-Q · filed 2018-05-08 | -$419.00K derived: sum of 2 quarters · filed 2019-03-01 | -$30.59M derived: sum of 3 quarters · filed 2019-03-01 | -$31.11M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-12-31 | -$8.86M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$39.03M derived: sum of 2 quarters · filed 2019-03-01 | -$39.55M derived: sum of 3 quarters · filed 2019-03-01 | -$77.23M 10-K · filed 2019-03-01 |
| 2017-09-30 | -$30.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$30.69M derived: sum of 2 quarters · filed 2018-11-09 | -$68.37M 10-Q · filed 2018-11-09 | -$44.28M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | -$522.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$38.20M 10-Q · filed 2018-08-07 | -$14.12M derived: sum of 3 quarters · filed 2019-03-01 | -$25.48M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | -$37.68M 10-Q · filed 2018-05-08 | -$13.59M derived: sum of 2 quarters · filed 2019-03-01 | -$24.96M derived: sum of 3 quarters · filed 2019-03-01 | -$43.92M derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | $24.09M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $12.72M derived: sum of 2 quarters · filed 2019-03-01 | -$6.24M derived: sum of 3 quarters · filed 2019-03-01 | -$24.86M 10-K · filed 2019-03-01 |
| 2016-09-30 | -$11.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$30.33M derived: sum of 2 quarters · filed 2017-11-08 | -$48.95M 10-Q · filed 2017-11-08 | -$67.50M derived: sum of 4 quarters · filed 2019-01-29 |
| 2016-06-30 | -$18.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$37.58M 10-Q · filed 2017-08-08 | -$56.13M derived: sum of 3 quarters · filed 2019-01-29 | -$65.20M derived: sum of 4 quarters · filed 2019-01-29 |
| 2016-03-31 | -$18.63M 10-Q · filed 2017-05-10 | -$37.17M derived: sum of 2 quarters · filed 2019-01-29 | -$46.24M derived: sum of 3 quarters · filed 2019-01-29 | -$173.22M derived: sum of 4 quarters · filed 2019-01-29 |
| 2015-12-31 | -$18.55M derived: 8-K 12 month − 10-Q 9 month · filed 2019-01-29 | -$27.62M derived: sum of 2 quarters · filed 2019-01-29 | -$154.59M derived: sum of 3 quarters · filed 2019-01-29 | $96.69M 8-K · filed 2019-01-29 |
| 2015-09-30 | -$9.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | -$136.05M derived: sum of 2 quarters · filed 2016-11-07 | $115.24M 10-Q · filed 2016-11-07 | $93.89M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | -$126.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $124.31M 10-Q · filed 2016-08-08 | $102.96M derived: sum of 3 quarters · filed 2017-03-01 | $87.21M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $251.28M 10-Q · filed 2016-05-09 | $229.93M derived: sum of 2 quarters · filed 2017-03-01 | $214.18M derived: sum of 3 quarters · filed 2017-03-01 | $191.80M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | -$21.35M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$37.10M derived: sum of 2 quarters · filed 2017-03-01 | -$59.49M derived: sum of 3 quarters · filed 2017-03-01 | -$88.89M 10-K · filed 2017-03-01 |
| 2014-09-30 | -$15.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$38.14M derived: sum of 2 quarters · filed 2015-11-09 | -$67.54M 10-Q · filed 2015-11-09 | -$37.58M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | -$22.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | -$51.79M 10-Q · filed 2015-08-05 | -$21.82M derived: sum of 3 quarters · filed 2016-02-29 | $14.95M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | -$29.40M 10-Q · filed 2015-05-11 | $562.00K derived: sum of 2 quarters · filed 2016-02-29 | $37.34M derived: sum of 3 quarters · filed 2016-02-29 | -$25.20M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $29.96M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $66.74M derived: sum of 2 quarters · filed 2016-02-29 | $4.20M derived: sum of 3 quarters · filed 2016-02-29 | $158.44M 10-K · filed 2016-02-29 |
| 2013-09-30 | $36.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | -$25.76M derived: sum of 2 quarters · filed 2014-11-07 | $128.47M 10-Q · filed 2014-11-07 | $132.41M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-06-30 | -$62.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $91.70M 10-Q · filed 2014-08-11 | $95.63M derived: sum of 3 quarters · filed 2015-02-27 | $80.89M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-03-31 | $154.24M 10-Q · filed 2014-05-09 | $158.17M derived: sum of 2 quarters · filed 2015-02-27 | $143.43M derived: sum of 3 quarters · filed 2015-02-27 | $134.48M derived: sum of 4 quarters · filed 2015-02-27 |
| 2012-12-31 | $3.93M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | -$10.81M derived: sum of 2 quarters · filed 2015-02-27 | -$19.76M derived: sum of 3 quarters · filed 2015-02-27 | -$44.16M 10-K · filed 2015-02-27 |
| 2012-09-30 | -$14.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$23.69M derived: sum of 2 quarters · filed 2013-11-12 | -$48.09M 10-Q · filed 2013-11-12 | -$23.81M derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-06-30 | -$8.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$33.34M 10-Q · filed 2013-08-09 | -$9.06M derived: sum of 3 quarters · filed 2014-03-03 | -$678.00K derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-03-31 | -$24.40M 10-Q · filed 2013-05-10 | -$117.00K derived: sum of 2 quarters · filed 2014-03-03 | $8.27M derived: sum of 3 quarters · filed 2014-03-03 | -$761.00K derived: sum of 4 quarters · filed 2014-03-03 |
| 2011-12-31 | $24.28M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $32.67M derived: sum of 2 quarters · filed 2014-03-03 | $23.64M derived: sum of 3 quarters · filed 2014-03-03 | $53.50M 10-K · filed 2014-03-03 |
| 2011-09-30 | $8.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | -$644.00K derived: sum of 2 quarters · filed 2012-11-09 | $29.22M 10-Q · filed 2012-11-09 | $32.06M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-06-30 | -$9.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $20.83M 10-Q · filed 2012-08-09 | $23.67M derived: sum of 3 quarters · filed 2013-03-18 | $29.16M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-03-31 | $29.86M 10-Q · filed 2012-05-10 | $32.70M derived: sum of 2 quarters · filed 2013-03-18 | $38.19M derived: sum of 3 quarters · filed 2013-03-18 | |
| 2010-12-31 | $2.84M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $8.33M derived: sum of 2 quarters · filed 2013-03-18 | -$24.64M 10-K · filed 2013-03-18 | |
| 2010-09-30 | $5.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | -$27.48M 10-Q · filed 2011-11-09 | ||
| 2010-06-30 | -$32.97M 10-Q · filed 2011-08-08 | |||
| 2009-12-31 | $35.98M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |